Drugmakers take steps to fend off future attacks
Worried about drawing Trump's ire, they aim to limit price increases and lobbying groups have pushed ahead with major campaigns intended to win back the narrative
New York
IF the nation's pharmaceutical executives thought Donald Trump would grant them a reprieve from scrutiny over high drug prices, he made them reconsider that idea in the last few days.
"I'm going to bring down drug prices," he told Time magazine in an interview published on Wednesday. "I don't like what's happened with drug prices."
Biotech stocks promptly fell nearly 3 per cent on Wednesday. They recovered …
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Consumer & Healthcare
Cordlife’s independent auditor to retire after issuing disclaimer of opinion on FY2023 financials
Cordlife customers push for legal action
France's Casino supermarket chain to axe up to 3,200 jobs
Prada outshines rivals with 16% revenue lift boosted by Miu Miu
Toymaker Hasbro posts quarterly profit beat, slower sales decline
Hilton lifts 2024 profit forecast on international travel demand